Symptomatic and chondroprotective treatment with collagen derivatives in osteoarthritis: A systematic review

Osteoarthritis and Cartilage

Volumn 20, Issue 8, 2012, Pages 809-821

  Van Vijven, J P J ^a   Luijsterburg, P A J ^a   Verhagen, A P ^a   van Osch, G J V M ^a   Kloppenburg, M ^b   Bierma Zeinstra, S M A ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Collagen derivatives; Collagen hydrolysate; Gelatine; Osteoarthritis; Undenatured collagen

Indexed keywords

ASCORBIC ACID; CALCIUM CARBONATE; CHONDROITIN; CHONDROITIN SULFATE; COLLAGEN DERIVATIVE; COLLAGEN HYDROLYSATE; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GELATIN; GLUCOSAMINE; PLACEBO; UNCLASSIFIED DRUG; UNDENATURED COLLAGEN;

CHONDROPROTECTION; DATA BASE; DATA EXTRACTION; DATA SYNTHESIS; DIARRHEA; DRUG EFFICACY; DYSPEPSIA; FLATULENCE; HUMAN; NAUSEA; OSTEOARTHRITIS; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; VISUAL ANALOG SCALE; WESTERN ONTARIO AND MCMASTER UNIVERSITIES OSTEOARTHRITIS INDEX;

CHONDROITIN; COLLAGEN; FEMALE; GELATIN; GLUCOSAMINE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PROTEIN HYDROLYSATES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME;

EID: 84862986592     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2012.04.008     Document Type: Review

References (40)

1. Lawrence R.C., Felson D.T., Helmick C.G., Arnold L.M., Choi H., Deyo R.A., et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008, 58:26-35.
2. Felson D.T., Lawrence R.C., Dieppe P.A., Hirsch R., Helmick C.G., Jordan J.M., et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors. Ann Intern Med 2000, 133:635-646.
3. Zhang W., Moskowitz R.W., Nuki G., Abramson S., Altman R.D., Arden N., et al. OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. Osteoarthritis Cartilage 2008, 16:137-162.
4. Qvist P., Bay-Jensen A.C., Christiansen C., Dam E.B., Pastoureau P., Karsdal M.A. The disease modifying osteoarthritis drug (DMOAD): is it in the horizon?. Pharmacol Res 2008, 58:1-7.
5. Oesser S., Adam M., Babel W., Seifert J. Oral administration of (14)C labelled gelatin hydrolysate leads to an accumulation of radioactivity in cartilage of mice (C57/BL). J Nutr 1999, 129:1891-1895.
6. Walrand S., Chiotelli E., Noirt F., Mwewa S., Lassel T. Consumption of a functional fermented milk containing collagen hydrolysate improves the concentration of collagen-specific amino acids in plasma. J Agric Food Chem 2008, 56:7790-7795.
7. Kyung-Su P., Min-Jung P., Mi-La C., Seung-Ki K., Ji Hyeon J., Hyeok-Jae K., et al. Type II collagen oral tolerance; mechanism and role in collagen-induced arthritis and rheumatoid arthritis. Mod Rheumatol 2009, 19:581-589.
8. Oesser S., Seifert J. Stimulation of type II collagen biosynthesis and secretion in bovine chondrocytes cultured with degraded collagen. Cell Tissue Res 2003, 311:393-399.
9. Schunck M., Schulze C.H., Oesser S. Disparate efficacy of collagen hydrolysate and glucosamine on the extracellular matrix metabolism of articular chondrocytes. Osteoarthritis Cartilage 2006, 14:S114.
10. Elder S.H., Borazjani A. Effect of collagen hydrolysate on chondrocyte-seeded agarose constructs. Biomed Mater Eng 2009, 19:409-414.
11. Ng K.W., Saliman J.D., Lin E.Y., Statman L.Y., Kugler L.E., Lo S.B., et al. Culture duration modulates collagen hydrolysate-induced tissue remodeling in chondrocyte-seeded agarose hydrogels. Ann Biomed Eng 2007, 35:1914-1923.
12. Bailey A.J., Mansell J.P. Do subchondral bone changes exacerbate or precede articular cartilage destruction in osteoarthritis of the elderly?. Gerontology 1997, 43:296-304.
13. Koyama Y., Hirota A.H., Irie S. Ingestion of gelatin has differential effect on bone mineral density and body weight in protein undernutrition. J Nutr Sci Vitaminol 2001, 47:84-86.
14. Nomura Y., Oohashi K., Watanabe M., Kasugai S. Increase in bone mineral density through oral administration of shark gelatin to ovariectomized rats. Nutrition 2005, 21:1120-1126.
15. Faria M., da Costa E.L., Gontijo J.A.R., Netto F.M. Evaluation of the hypotensive potential of bovine and porcine collagen hydrolysates. J Med Food 2008, 11:560-567.
16. Saiga-Egusa A., Iwai K., Hayakawa T., Takahata Y., Morimatsu F. Antihypertensive effects and endothelial progenitor cell activation by intake of chicken collagen hydrolysate in pre- and mild-hypertension. Biosci Biotechnol Biochem 2009, 73:422-424.
17. Zhang Y., Koguchi T., Simizu M., Ohmori T., Takahata Y., Morimatsu F. Chicken collagen hydrolysate protects rats from hypertension and cardiovascular damage. J Med Food 2010, 13:399-405.
18. Conaghan P.G., Vanharanta H., Dieppe P.A. Is progressive osteoarthritis an atheromatous vascular disease?. Ann Rheum Dis 2005, 64:1539-1541.
19. Pham T., van der Heijde D., Altman R.D., Anderson J.J., Bellamy N., Hochberg M., et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004, 12:389-399.
20. Furlan A.D., Pennick V., Bombardier C., van Tulder M., Editorial Board and Cochrane Back Review Group 2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group. Spine 2009, 34:1929-1941.
21. Guyatt G.H., Oxman A.D., Kunz R., Vist G.E., Falck-Ytter Y., Schünemann H.J. GRADE Working Group. What is "quality of evidence" and why is it important to clinicians?. BMJ 2008, 336:995-998.
22. Kellgren J.K., Lawrence J.S. Radiological assessment of osteoarthritis. Ann Rheum Dis 1957, 16:494-502.
23. Adam M. What effects do Gelatin Preparations have?. Therapiewoche 1991, 41:2456-2461.
24. Benito-Ruiz P., Camacho-Zambrano M.M., Carillo-Arcentales J.N., Mestanza-Peralta M.A., Vallejo-Flores C.A., Vargas-López S.V., et al. A randomized controlled trial on the efficacy and safety of a food ingredient, collagen hydrolysate, for improving joint comfort. Int J Food Sci Nutr 2009, 60:99-113.
25. Crowley D.C., Lau F.C., Sharma P., Evans M., Guthrie N., Bagchi M., et al. Safety and efficacy of undenatured type II collagen in the treatment of osteoarthritis of the knee: a clinical trial. Int J Med Sci 2009, 6:312-321.
26. McAlindon T.E., Nuite M., Krishnan N., Ruthazer R., Price L.L., Burstein D., et al. Change in knee osteoarthritis cartilage detected by delayed gadolinium enhanced magnetic resonance imaging following treatment with collagen hydrolysate: a pilot randomized controlled trial. Osteoarthritis and Cartilage 2011, 19:399-405.
27. McCarthy S, Carpenter MR, Barrell MM, Morrissey DE, Jacobson E, Kline G, et al. The effectiveness of gelatine supplementation treatment in individuals with symptoms of mild osteoarthritis. A randomized, doubleblind, placebo-controlled study. US Family Practice News 2000; American Academy of Family Physicians. Annual Assembly. Dallas (TX).
28. Moskowitz R.W. Role of collagen hydrolysate in bone and joint disease. Semin Arthritis Rheum 2000, 30:87-99.
29. Oberschelp U. Individual treatment of osteoarthritis is possible. Therapiewoche 1985, 35:5094-5097.
30. Trč T., Bohmova J. Efficacy and tolerance of enzymatic hydrolysed collagen (EHC) vs glucosamine sulphate (GS) in the treatment of knee osteoarthritis (KOA). Int Orthop 2010, 35:341-348.
31. Orwin R.G. Evaluating coding decisions. The Handbook of Research Synthesis 1994, 139-162. Russell Sage Foundation, New York. H. Cooper, H. Lv (Eds.).
32. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] 2011, The Cochrane Collaboration, Available from:, Chapter 10. http://www.cochrane-handbook.org, J.P.T. Higgins, S. Green (Eds.).
33. Ameye L.G., Chee W.S.S. Osteoarthritis and nutrition. From nutraceuticals to functional foods: a systematic review of the scientific evidence. Arthritis Res Ther 2006, 8:R127.
34. Bello A.E., Oesser S. Collagen hydrolysate for the treatment of osteoarthritis and other joint disorders: a review of the literature. Curr Med Res Opin 2006, 22:2221-2232.
35. Clark K.L. Nutritional Considerations in joint health. Clin Sports Med 2007, 26:101-118.
36. Clayton J.J. Nutraceuticals in the management of osteoarthritis. Orthopedics 2007, 30:624-629.
37. Flechsenhar K. Fortigel - a new concept for the treatment of osteoarthritis. Agro Food Industry Hi-tech 2007, 18.
38. Henrotin Y., Lambert C., Couchourel D., Ripoll C., Chiotelli E. Nutraceuticals: Do they represent a new era in the management of osteoarthritis? - a narrative review from the lessons taken with five products. Osteoarthritis and Cartilage 2011, 19:1-21.
39. Hunter D.J. Pharmacologic therapy for osteoarthritis-the era of disease modification. Nat Revi Rheumatol 2011, 7:13-22.
40. Kasper H. Nutrition and degenerative joint diseases. The chondroprotective action of gelatin. Medizinische Welt 2003, 54:47-49.